Pre-order Enquiry
Request Free Sample
Hepatic Encephalopathy- Epidemiology Forecast-2028
SKU ID : DEL-14679803 | Publishing Date : 01-Sep-2019 | No. of pages : 80
Request Sample
Request Customization
Check DiscountsDetailed TOC of Hepatic Encephalopathy- Epidemiology Forecast-2028
1. Key Insights2. Hepatic Encephalopathy Market Overview at a Glance
2.1. Market Share (%) Distribution of Hepatic Encephalopathy (HE) in 2017
2.2. Market Share (%) Distribution of Hepatic Encephalopathy (HE) in 2028
3. Hepatic Encephalopathy (HE): Disease Background and Overview
3.1. Introduction
3.2. Classification of Hepatic Encephalopathy
3.3. Symptoms of Hepatic Encephalopathy
3.4. Cause and risk factors of Hepatic Encephalopathy
3.5. Pathophysiology
3.6. Pathogenesis of Hepatic Encephalopathy
3.7. Diagnosis
3.8. The differential diagnosis for Hepatic Encephalopathy
3.9. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Methodology
4.3. 7MM Total Prevalent Patient Population of Hepatic Encephalopathy
4.4. 7MM Total Diagnosed Prevalent Patient Population of Hepatic Encephalopathy
5. Country Wise-Epidemiology of Hepatic Encephalopathy
5.1. United States Epidemiology
5.1.1. Assumptions and Rationale
5.1.2. Total Prevalent Cases of Hepatic Encephalopathy in the United States
5.1.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in the United States
5.1.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States
5.1.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States
5.1.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States
5.2. EU5 Epidemiology
5.2.1. Germany
5.2.1.1. Assumptions and Rationale
5.2.1.2. Total Prevalent Cases of Hepatic Encephalopathy in Germany
5.2.1.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Germany
5.2.1.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany
5.2.1.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany
5.2.1.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany
5.2.2. France
5.2.2.1. Assumptions and Rationale
5.2.2.2. Total Prevalent Cases of Hepatic Encephalopathy in France
5.2.2.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in France
5.2.2.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France
5.2.2.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France
5.2.2.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France
5.2.3. Italy
5.2.3.1. Assumptions and Rationale
5.2.3.2. Total Prevalent Cases of Hepatic Encephalopathy in Italy
5.2.3.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Italy
5.2.3.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy
5.2.3.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy
5.2.3.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy
5.2.4. Spain
5.2.4.1. Assumptions and Rationale
5.2.4.2. Total Prevalent Cases of Hepatic Encephalopathy in Spain
5.2.4.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Spain
5.2.4.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain
5.2.4.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain
5.2.4.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain
5.2.5. United Kingdom
5.2.5.1. Assumptions and Rationale
5.2.5.2. Total Prevalent Cases of Hepatic Encephalopathy in the United Kingdom
5.2.5.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in the United Kingdom
5.2.5.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the UK
5.2.5.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the UK
5.2.5.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the UK
6. Japan Epidemiology
6.1. Assumptions and Rationale
6.2. Total Prevalent Cases of Hepatic Encephalopathy in Japan
6.3. Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Japan
6.4. Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan
6.5. Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan
6.6. Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan
7. Appendix
7.1. Report Methodology
8. DelveInsight Capabilities
9. Disclaimer
10. About DelveInsight
List of Figures, Tables and Charts Available in Hepatic Encephalopathy- Epidemiology Forecast-2028
Table 1 Clinical Description of Hepatic Encephalopathy (Adapted from AASLD-EASL Guideline 2014Table 2 West Haven Criteria for hepatic encephalopathy and symptoms
Table 3 Stages of Hepatic Encephalopathy (HE)
Table 4 Total Prevalent Patient Population of Hepatic Encephalopathy in 7MM (2017-2028)
Table 5 Total Diagnosed Prevalent Patient Population of Hepatic Encephalopathy in 7MM (2017-2028)
Table 6 Total Prevalent Population of Hepatic Encephalopathy in the United States (2017-2028)
Table 7 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in the United States (2017-2028)
Table 8 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States (2017-2028)
Table 9 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States (2017-2028)
Table 10 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States (2017-2028)
Table 11 Total Prevalent Population of Hepatic Encephalopathy in Germany (2017-2028)
Table 12 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in Germany (2017-2028)
Table 13 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany (2017-2028)
Table 14 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany (2017-2028)
Table 15 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany (2017-2028)
Table 16 Total Prevalent Population of Hepatic Encephalopathy in France (2017-2028)
Table 17 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in France (2017-2028)
Table 18 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France (2017-2028)
Table 19 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France (2017-2028)
Table 20 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France (2017-2028)
Table 21 Total Prevalent Population of Hepatic Encephalopathy in Italy (2017-2028)
Table 22 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in Italy (2017-2028)
Table 23 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy (2017-2028)
Table 24 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy (2017-2028)
Table 25 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy (2017-2028)
Table 26 Total Prevalent Population of Hepatic Encephalopathy in Spain (2017-2028)
Table 27 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in Spain (2017-2028)
Table 28 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain (2017-2028)
Table 29 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain (2017-2028)
Table 30 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain (2017-2028)
Table 31 Total Prevalent Population of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Table 32 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Table 33 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Table 34 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Table 35 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Table 36 Total Prevalent Population of Hepatic Encephalopathy in Japan (2017-2028)
Table 37 Total Diagnosed Prevalent Population of Hepatic Encephalopathy in Japan (2017-2028)
Table 38 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan (2017-2028)
Table 39 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan (2017-2028)
Table 40 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan (2017-2028)
Figure 1 Symptoms of Hepatic Encephalopathy
Figure 2 Grading of the symptoms of Hepatic Encephalopathy
Figure 3 Symptoms of Hepatic Encephalopathy
Figure 4 Pathophysiology of hepatic encephalopathy
Figure 5 Pathophysiology of hepatic encephalopathy
Figure 6 Ammonia trafficking in hepatic encephalopathy (HE) from an organism (left panel) and an organ (right panel) perspective
Figure 7 The classification of HE, adapted from Amodio et al.
Figure 8 Total Prevalent Cases of Hepatic Encephalopathy in the 7MM (2017-2028)
Figure 9 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in the 7MM (2017-2028)
Figure 10 Total Prevalent Cases of Hepatic Encephalopathy in the United States (2017-2028)
Figure 11 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in the United States (2017-2028)
Figure 12 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States (2017-2028)
Figure 13 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States (2017-2028)
Figure 14 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United States (2017-2028)
Figure 15 Total Prevalent Cases of Hepatic Encephalopathy in Germany (2017-2028)
Figure 16 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Germany (2017-2028)
Figure 17 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany (2017-2028)
Figure 18 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany (2017-2028)
Figure 19 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Germany (2017-2028)
Figure 20 Total Prevalent Cases of Hepatic Encephalopathy in France (2017-2028)
Figure 21 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in France (2017-2028)
Figure 22 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France (2017-2028)
Figure 23 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France (2017-2028)
Figure 24 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in France (2017-2028)
Figure 25 Total Prevalent Cases of Hepatic Encephalopathy in Italy (2017-2028)
Figure 26 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Italy (2017-2028)
Figure 27 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy (2017-2028)
Figure 28 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy (2017-2028)
Figure 29 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Italy (2017-2028)
Figure 30 Total Prevalent Cases of Hepatic Encephalopathy in Spain (2017-2028)
Figure 31 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Spain (2017-2028)
Figure 32 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain (2017-2028)
Figure 33 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain (2017-2028)
Figure 34 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Spain (2017-2028)
Figure 35 Total Prevalent Cases of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Figure 36 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Figure 37 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Figure 38 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Figure 39 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in the United Kingdom (2017-2028)
Figure 40 Total Prevalent Cases of Hepatic Encephalopathy in Japan (2017-2028)
Figure 41 Total Diagnosed Prevalent Cases of Hepatic Encephalopathy in Japan (2017-2028)
Figure 42 Gender-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan (2017-2028)
Figure 43 Age-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan (2017-2028)
Figure 44 Type-Specific Diagnosed Prevalence of Hepatic Encephalopathy in Japan (2017-2028)
